Hims stock has rallied almost 22% this week on enthusiasm after the FDA said it will allow compounded versions of Lilly's ...

Providing coverage for weight-loss drugs such as Wegovy and Ozempic is forcing employers to make some critical decisions.

Pharmacists can continue making compounded versions of generic tirzepatide, the active ingredient in popular medications ...

Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound to be no ...

Hoping your company will begin paying for anti-obesity medications like Wegovy? You may be in luck. A growing number of ...

The FDA said in a court filing late Friday that it would allow pharmacists to continue making compounded versions of ...

For now, semaglutide remains on the FDA's shortages list in the lowest dose of Wegovy, the version approved for weight ...

Ozempic was first approved in 2017 by the United States (US) Food and Drug Administration (FDA) as an injectable drug to help “lower blood sugar levels in adults with type 2 diabetes mellitus, in ...

Fourteen years ago, the older drug cousin of semaglutide (Ozempic and Wegovy) came onto the market ... This hormone is released from your small intestines in response to food and acts in several ways ...

Bloomberg / Contributor / Getty Images Hims & Hers Health shares tumbled Thursday after the Food and Drug Administration (FDA) said Eli Lilly's popular weight-loss drugs are no longer on its list ...

(Reuters) -The U.S. Food and Drug Administration removed Eli Lilly's blockbuster weight-loss and diabetes drugs from its shortage list late on ... drugs Ozempic and Wegovy, is also ramping up ...

Sarah House, a 27-year-old in Seattle, is also accustomed to turning to food when she’s stressed. When she started taking the weight loss drug Wegovy last ... s a long list of products that ...